Alector Inc (ALEC)
4.065
-0.84
(-17.21%)
USD |
NASDAQ |
Nov 15, 16:00
4.065
0.00 (0.00%)
After-Hours: 20:00
Alector Research and Development Expense (TTM): 187.20M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 187.20M |
| June 30, 2024 | 185.53M |
| March 31, 2024 | 185.40M |
| December 31, 2023 | 192.12M |
| September 30, 2023 | 198.88M |
| June 30, 2023 | 200.90M |
| March 31, 2023 | 209.26M |
| December 31, 2022 | 210.42M |
| September 30, 2022 | 208.72M |
| June 30, 2022 | 203.43M |
| March 31, 2022 | 196.72M |
| December 31, 2021 | 189.41M |
| September 30, 2021 | 181.00M |
| Date | Value |
|---|---|
| June 30, 2021 | 181.75M |
| March 31, 2021 | 168.00M |
| December 31, 2020 | 156.87M |
| September 30, 2020 | 138.25M |
| June 30, 2020 | 122.95M |
| March 31, 2020 | 114.53M |
| December 31, 2019 | 100.53M |
| September 30, 2019 | 98.86M |
| June 30, 2019 | 90.74M |
| March 31, 2019 | 81.91M |
| December 31, 2018 | 73.03M |
| September 30, 2018 | 59.77M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
100.53M
Minimum
Dec 2019
210.42M
Maximum
Dec 2022
176.59M
Average
186.37M
Median
Research and Development Expense (TTM) Benchmarks
| Precision BioSciences Inc | 57.04M |
| NovaBay Pharmaceuticals Inc | 0.064M |
| Palatin Technologies Inc | 22.40M |
| iBio Inc | 5.185M |
| Theriva Biologics Inc | 14.61M |